ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
68 950,54
-0,46%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AYTU BioPharma Inc (AYTU)

  7. AYTU BioPharma Inc (AYTU) Actualités

AYTU

AYTU BioPharma (AYTU)

AYTU BioPharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AYTU
DateHeureSourceTitreSymboleSociété
15/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AYTUAYTU BioPharma Inc
10/05/202422h07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AYTUAYTU BioPharma Inc
10/05/202422h07Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AYTUAYTU BioPharma Inc
10/05/202422h06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AYTUAYTU BioPharma Inc
13/02/202422h25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AYTUAYTU BioPharma Inc
02/01/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AYTUAYTU BioPharma Inc
14/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AYTUAYTU BioPharma Inc
12/10/202320h50Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AYTUAYTU BioPharma Inc
29/09/202322h15Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:AYTUAYTU BioPharma Inc
27/09/202313h28IH Market NewsWednesday’s Wall Street Highlights: Amazon, Costco, Sirius XM, Electronic Arts, Peloton, and moreNASDAQ:AYTUAYTU BioPharma Inc
23/06/202322h55Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AYTUAYTU BioPharma Inc
22/06/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AYTUAYTU BioPharma Inc
20/06/202314h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AYTUAYTU BioPharma Inc
16/06/202322h49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AYTUAYTU BioPharma Inc
12/06/202323h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AYTUAYTU BioPharma Inc
12/06/202323h12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AYTUAYTU BioPharma Inc
09/06/202314h11Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:AYTUAYTU BioPharma Inc
05/06/202323h25Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:AYTUAYTU BioPharma Inc
26/05/202319h53Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AYTUAYTU BioPharma Inc
11/05/202322h05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AYTUAYTU BioPharma Inc
01/05/202323h21Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:AYTUAYTU BioPharma Inc
15/02/202322h41Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AYTUAYTU BioPharma Inc
16/11/202212h25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aytu BioScience (AYTU)NASDAQ:AYTUAYTU BioPharma Inc
14/11/202223h52Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AYTUAYTU BioPharma Inc
21/09/202214h00Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AYTUAYTU BioPharma Inc
15/08/202222h03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AYTUAYTU BioPharma Inc
23/06/202212h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AYTUAYTU BioPharma Inc
08/06/202222h07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AYTUAYTU BioPharma Inc
28/04/202212h17TipRanksH.C. Wainwright Thinks Aytu BioScience’s Stock is Going to RecoverNASDAQ:AYTUAYTU BioPharma Inc
04/03/202212h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:AYTUAYTU BioPharma Inc
 Showing the most relevant articles for your search:NASDAQ:AYTU

Dernières Valeurs Consultées

EU
GLE
Societe Generale
EU
VIV
Vivendi
NYSE
KO
Coca Cola
NYSE
MRK
Merck
NYSE
NKE
Nike
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
NASDAQ
GOOGL
Alphabet
EU
VK
Vallourec
FTSE
UKX
FTSE 100
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés